New Agents

To discover new agents active against methicillin-resistant Staphylococcus aureus (MRSA), in silico models derived from 5451 cell… (More)

Interleukin 13 receptor alpha 2 (IL-13RA2) is over-expressed in a vast majority of human patients with high-grade astrocytomas… (More)

OPINION STATEMENT The treatment of migraine was advanced dramatically with the introduction of triptans in the early 1990s… (More)

Glioblastoma is the most common malignant glioma in adults, and despite recent advances in standard treatment, the prognosis… (More)

Despite both the increase in basic biologic knowledge and the fact that many new agents have reached various stages of… (More)

The primary clinical outcome measure for evaluating multiple sclerosis in clinical trials has been Kurtzke's expanded disability… (More)

In the early drug development process for cancer therapy, several ethical dilemmas result from the use of cancer patients with… (More)

We report a multicentre phase II study of orally administered prolonged schedule etoposide in children with refractory or… (More)

Standardization of terminology used to describe the pattern and course of MS is essential for mutual understanding between… (More)

Fludarabine Monophosphate (FLU) is an adenosine analogue with a high-level of anti-leukemic activity in patients (pts) with CLL… (More)